Articles tagged with Vaccination
A recent study published in the American Journal of Medical Genetics found no association between Rh immune globulin preserved with thimerosal and an increased risk of autism. Researchers investigated the exposure to thimerosal during pregnancies resulting in children diagnosed with autism and found no correlation.
Female ixodid ticks exhibit remarkable weight gain following mating, with some species increasing in size up to 100 times their original size. This phenomenon is linked to the tick's unique lifestyle and reproductive strategy, which involves prolonged feeding periods and specialized signals triggered by copulation.
A study published in Immunology Letters describes new ways of inducing immune responses through selective B cell priming, suggesting a potential approach to rational vaccine design. This discovery could have significant practical implications for vaccination development.
Researchers at Mayo Clinic have developed a breast cancer vaccine that successfully stimulated an anti-tumor T cell response in female mouse models, slowing or stopping the progression of breast cancer. The vaccine's effectiveness was achieved by combining synthetic peptides with a Toll-like receptor stimulant and anti-CD25 antibodies.
A rare case of hepatitis B virus transmission between two patients at a dentist's office has been documented, highlighting the need for meticulous infection control. Universal vaccination against HBV would likely have prevented both cases.
The Kirk A. Landon-AACR Prize for Basic Cancer Research recognizes Dr. Richard Kolodner for his work on DNA mismatch repair and its connection to human cancer. The Dorothy P. Landon-AACR Prize for Translational Cancer Research honors Douglas Lowy and John Schiller for their development of the human papillomavirus vaccine.
Dr. Russell is recognized for his contributions to understanding the protein antigens on Streptococcus mutans, a bacterium associated with dental caries. His work has led to the development of immunological interventions targeting this adhesin and improved mucosal immune response strategies.
Researchers found that flies' primitive immune systems can adapt and retain memory of an earlier infection, contradicting the long-held dogma. This discovery raises possibilities for developing human vaccines, especially for people with compromised immune systems.
Professor Ian Frazer, a renowned cancer vaccine innovator, has been awarded the prestigious Florey Medal for his groundbreaking work on cervical cancer prevention. The award recognizes the significant public health impact of his research, which aims to control cervical cancer rates in developing countries.
A national study estimates that approximately 1 in 4 U.S. females between 14 and 59 years old may have HPV infection, with the highest prevalence among younger women. The study also found a significant trend for increasing HPV prevalence with age, followed by a decline through 59 years.
Researchers at Harvard University have created a novel spraying method for delivering the most common tuberculosis (TB) vaccine, offering needle-free delivery and greater stability. This breakthrough could improve TB care and slow the spread of HIV/AIDS in developing countries.
A novel spray drying method has been developed to preserve and deliver the most common tuberculosis (TB) vaccine, promising greater stability at room temperature and use in needle-free delivery. This technique could provide a better approach for vaccination against TB and help prevent the spread of HIV/AIDS in developing countries.
Researchers warn that an immuno-contraception vaccine, which aims to control wildlife populations, is not fully effective and may manipulate natural reproduction in unpredictable ways. The vaccine also raises concerns about the potential for individuals who survive the vaccine to carry infectious diseases affecting other animals.
Researchers have discovered a protein, GAPDH, that allows group B streptococci to colonize and cause infection in newborns. The protein modulates the immune system, increasing the risk of invasive bacterial infection.
Researchers used toll-like receptor agonists to stimulate an immune response against breast cancer tumors, preventing spontaneous growth and slowing tumor development. The vaccine was most effective when given prior to tumor appearance, extending survival but not curing the disease.
A study found that pneumococcal vaccination can prevent 262,000 child deaths annually. The vaccine's net cost of $838 million is considered cost-effective due to the significant reduction in child mortality.
A study by Stanford researchers found that while 41% of autism research deals with brain and behavior, only 11% of media coverage addresses these topics. Instead, 48% focus on environmental causes, such as the childhood MMR vaccine, highlighting a stark disconnect between scientific research and public perception.
A pre-hatching prototype vaccine virus providing immunity against infectious bronchitis virus (IBV) has been developed by scientists at the Institute for Animal Health and Intervet UK. The vaccine can be delivered to chicks still in their egg using robotic 'vaccinators' and has shown protection rates of up to 100 percent.
A study found that only 40% of US women have ever heard of HPV, and fewer still know about its connection to cervical cancer. The public needs education on HPV and cervical cancer to make informed health care choices, researchers concluded.
A recent study found that vaccinating mice with embryonic stem cells prevented lung cancer in those exposed to cancer-causing chemicals or had transplanted cancer cells. The vaccines showed promise in preventing tumour growth and were up to 100% effective, with smaller tumours developing in vaccinated mice.
A review in the Journal of Internal Medicine estimates that 50 million people acquired zoonotic diseases between 2000 and 2005, resulting in up to 78,000 deaths. The Dengue virus and Japanese Encephalitis Virus are among the most common zoonotic killers.
Researchers at CReSA have made significant advances in tests using DNA vaccines on animal models, enabling a delay in symptom appearance and paving the way for human treatment. The vaccine induces a complete immune response, including humoral and cellular responses, overcoming the tolerance barrier faced by prions.
A new Staphylococcus aureus vaccine has been developed by combining four proteins that generated the strongest immune response in mice, providing significant protection against various strains of the bacterium. The vaccine showed complete protection when tested against a human strain of S. aureus.
Researchers found a two- or three-dose schedule may be as effective as the traditional four-dose schedule in preventing pneumococcal disease in young children. The vaccine showed high effectiveness against seven strains of Streptococcus pneumoniae, with 96% efficacy in healthy children and 81% in those at risk.
A new MUHC study provides conclusive evidence that the MMR vaccine is not associated with autism spectrum disorders. The study's findings contradict previous molecular studies that falsely linked the vaccine to autism. The research team uncovered fundamental errors in these earlier studies, clearing the MMR vaccine of its link to autism.
States with personal belief exemptions and easily accessible immunization exemptions experience higher rates of whooping cough, according to a study published in JAMA. The study found that states granting personal belief exemptions had higher exemption rates, leading to increased incidence of pertussis.
The European Union should make vaccination against the human papillomavirus (HPV) mandatory for all girls aged 11-12 years to prevent cervical cancer. The vaccine offers protection against HPV types 16 and 18, responsible for 70% of all cervical cancers.
Researchers developed a DNA-based vaccine to protect against ragweed allergies, showing a 60% reduction in symptoms. The vaccine works by suppressing acute reactions and helping the body regulate chronic inflammation.
Researchers discovered that West Nile virus blocks immune signaling by a protein receptor, allowing it to replicate and spread. The African strain does not block this activity, making it harmless to the immune system. Harnessing this strain could lead to vaccine development against North American strains.
OHSU researchers show that CD8+ T-cells can literally eat virus-infected cells, providing insight into the human immune system and potential new way to gauge vaccine effectiveness. The discovery may help determine vaccine efficacy by measuring T-cell response to and consumption of a candidate vaccine.
A landmark publication from 100 authors offers comprehensive guidance on HPV vaccine administration and cervical cancer screening. The monograph addresses the challenges of expanding HPV-based screening to new populations and recommends universal vaccination strategies for both genders.
Radiation therapy significantly reduces risk of subsequent mastectomy and invasive breast cancer in both low- and high-risk patients with ductal carcinoma in situ (DCIS). Autoimmune conditions are also associated with increased risk of Hodgkin lymphoma, according to two new studies.
Researchers found that children exposed to polychlorinated biphenyls (PCBs) receive lower antibody protection after vaccinations. The study suggests that reducing exposure to chemicals that harm immune systems is crucial for young children.
A new study published in Vaccine found that a recombinant Protective Antigen (PA) protein vaccine produced the desired immune response in healthy adults, justifying further testing. The investigational vaccine demonstrated a clear relationship between the amount of vaccine administered and the subsequent immune response.
A new anti-obesity vaccine has shown promising results by slowing down weight gain and reducing body fat in animal models. The vaccine, targeting the hormone ghrelin, allowed rats to maintain normal eating habits while gaining less weight and accumulating less fat.
The Baylor Institute for Immunology Research has been awarded a $3 million grant to develop vaccines against melanoma, a deadly form of skin cancer. The research will focus on using dendritic cells to modulate the immune system and stimulate an anti-cancer response.
A study by Dr. Eric Fombonne and colleagues found no link between MMR vaccinations and autism rates in Quebec children, contradicting previous concerns. The incidence of autism remained high despite reductions in thimerosal use.
Researchers developed a strategy combining two human monoclonal antibodies to combat SARS virus, offering potential breadth of protection against all strains and preventing escape variants. The study presents the characteristics of this antibody combination in cell-culture experiments.
A heat-shock protein vaccine was found to reduce alveolar bone loss in patients with periodontal disease. The vaccine eradicated multiple pathogenic species, suggesting its potential as a treatment for periodontal disease.
A study shows that a prostate cancer vaccine, sipuleucel-T, can increase survival by up to four-and-a-half months and provide a greater than three-fold increase in survival at 36 months compared to patients in the placebo group. The vaccine was well-tolerated with mild adverse effects.
The introduction of Gardasil in the USA is proving problematic due to social and cultural resistance. The Bill and Melinda Gates Foundation has donated $27.7 million to PATH to research introducing the vaccine in developing countries, where Merck and GSK can assist by identifying cultural barriers.
University of Rochester experts discuss how flu invades and responds to the body, with a focus on understanding its pathogenesis. The research aims to prevent potential modification of the flu virus for lethal use and develop more effective treatments.
Researchers have identified a protein peptide that regulates the immune system and prevents autoimmune disease in Type 1 diabetes. The peptide, p277, stimulates regulatory T cells to produce anti-inflammatory substances, weakening the immune response.
A new vaccine called NicVax is being tested to prevent and treat nicotine addiction, with the goal of helping smokers quit. The vaccine works by stimulating the immune system to produce antibodies that recognize nicotine molecules, preventing them from entering the brain.
Dental caries is a widespread and increasing problem globally, with 5 billion people affected. Forsyth researchers aim to develop a vaccine targeting bacterial accumulation on teeth, with initial focus on mucosal vaccines for young children.
A study conducted by Yale University researchers found that Iraqi nurses require improved working conditions, equipment, and financial support to ensure the success of the healthcare system. The nurses also emphasized the importance of respect from physicians, administrators, and society at large.
Researchers found that a vaccine combined with short-term antibiotic treatment can protect nonhuman primates from inhalational anthrax. The study suggests that this combination may be crucial for successful defense against large-scale anthrax attacks, minimizing the risk of adverse events and improving public health management.
A combination of interventions could be highly effective at reducing transmission in a flu pandemic, potentially saving many lives. School closure combined with antiviral drugs can halve the number of people getting ill.
A new experimental vaccine has been shown to protect nonhuman primates against Marburg virus infection, even when administered after exposure. The study found that all treated monkeys survived for at least 80 days, while controls succumbed to the disease within 12 days.
Researchers have developed a vaccine that prevents haemorrhagic fever developing in monkeys infected with the deadly Marburg virus. The vaccine was found to be highly effective as a post-exposure treatment, with all treated monkeys surviving for at least 80 days.
Negative publicity in 1998 led to a sharp increase in MMR vaccine uptake among nursery school children, with the sharpest decline occurring for those born from 1999 onwards. The most affluent sectors tended to vaccinate early or not at all, while parents in deprived areas delayed vaccination.
Researchers found that blood tests T-SPOT.TB and QuantiFERON-TB Gold show good diagnostic agreement with the skin test, but have higher specificity. This suggests they could increase diagnostic sensitivity in testing for latent TB infection. However, results differ between blood tests, especially in immunosuppressed patients and young ...
Researchers propose a $500 million upfront investment to secure a 12-month vaccine supply, protecting 11,000 daily births from potential shortages. The CDC's six-month plan is deemed unclear given the actual production interruption timelines.
A new analysis reveals that combination vaccines significantly increased on-time immunization rates in infants. The study found that the combination group had a 42.7% on-time rate for the HEDIS Combo 2 series, compared to 34.9% in the component group.
The BCG vaccine is highly cost-effective in preventing severe childhood tuberculosis, with an estimated cost of US$200 per year of healthy life gained. The largest impact was found in southeast Asia, Africa, and the western Pacific region, where TB infection rates and BCG coverage are highest.
A vaccine against cervical cancer has shown sustained high levels of antibodies for up to 4.5 years, providing substantial long-term protection against cancerous cell changes associated with high-risk HPV types. The vaccine was also found to be effective against persistent and new infections, setting the stage for its widescale adoption.
A new approach to controlling swine disease, known as acclimatization, was tested on a farm in Illinois. The study found that pigs exposed to the farm's wild-type virus developed immunity but suffered reproductive issues, casting doubt on its effectiveness.
The HPV vaccine has the potential to prevent cervical cancer, but understanding its context is vital. Vaccination should not be misconstrued as a green light for permissive behavior, but rather as a means of preventing infection in young women.
Researchers recommend vaccination campaigns, visa quotas, and rapid repatriation to minimize health hazards during the Hajj. International collaboration is crucial in managing the overwhelming task of Hajj management.
A new study reveals that people with eczema may benefit from smallpox vaccination due to their immune system's overproduction of inflammation-promoting molecules. The research suggests that developing drugs or creams to mimic the action of LL-37 or neutralizing IL-4 and IL-13 could be effective in boosting the immune response.